Investors Press Releases Jun 28 2024 Tiziana Receives $3.4 Million in Non-Dilutive Funding Read More Jun 26 2024 Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer’s Disease with Foralumab Read More Jun 11 2024 FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclerosis Read More btn News View All Events & Presentations Dec 14 2023 at 8:30 AM EST Dec 14 2023 at 8:30 AM EST Annual General Meeting 2023 Read More Jun 05 2023 at 12:30 PM EDT Jun 05 2023 at 12:30 PM EDT Tiziana Life Sciences: Foralumab Update in Non-Active Secondary Progressive Multiple Sclerosis (na SPMS) Read More Jan 09 2023 - Jan 11 2023 Jan 09 2023 - Jan 11 2023 Biotech Showcase Read More btn Events View All Interim Reports Interim Results for the Six Months Ended 30 June 2023 863.7 KB bth Interim Reports View All Annual Reports 20 F - Annual Report for the year ended 31 December 2023 8.9 MB btn ARs View All Annual General Meeting 2023 AGM Results 45.9 KB btn AGM View All Stock Quote Change Volume Today's Open Previous Close Today's High Today's Low 52 Week High 52 Week Low Stock Chart
Jun 26 2024 Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer’s Disease with Foralumab Read More
Jun 11 2024 FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclerosis Read More
Jun 05 2023 at 12:30 PM EDT Jun 05 2023 at 12:30 PM EDT Tiziana Life Sciences: Foralumab Update in Non-Active Secondary Progressive Multiple Sclerosis (na SPMS) Read More